Listed

Thermo Fisher Scientific Inc.: Form 10-Q for the period ended Jun 28, 2014

Filed with the SEC on Aug 1, 2014 and accepted by EDGAR at Aug 1, 2014, 11:33 ET.

Share

Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2014-06-28. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue3 months2014-03-30 to 2014-06-28$4.32bnus-gaap:Revenues
Revenue6 months2014-01-01 to 2014-06-28$8.23bnus-gaap:Revenues
Cost of revenue3 months2014-03-30 to 2014-06-28$2.11bnus-gaap:CostOfGoodsSold
Cost of revenue6 months2014-01-01 to 2014-06-28$4.05bnus-gaap:CostOfGoodsSold
Research and development3 months2014-03-30 to 2014-06-28$183.7mus-gaap:ResearchAndDevelopmentExpense
Research and development6 months2014-01-01 to 2014-06-28$333.4mus-gaap:ResearchAndDevelopmentExpense
Selling, general and administrative3 months2014-03-30 to 2014-06-28$1.25bnus-gaap:SellingGeneralAndAdministrativeExpense
Selling, general and administrative6 months2014-01-01 to 2014-06-28$2.43bnus-gaap:SellingGeneralAndAdministrativeExpense
Operating income3 months2014-03-30 to 2014-06-28$348.1mus-gaap:OperatingIncomeLoss
Operating income6 months2014-01-01 to 2014-06-28$1.22bnus-gaap:OperatingIncomeLoss
Interest expense3 months2014-03-30 to 2014-06-28$129.1mus-gaap:InterestExpense
Interest expense6 months2014-01-01 to 2014-06-28$246.9mus-gaap:InterestExpense
Income tax3 months2014-03-30 to 2014-06-28−$42.0mus-gaap:IncomeTaxExpenseBenefit
Income tax6 months2014-01-01 to 2014-06-28$189.3mus-gaap:IncomeTaxExpenseBenefit
Net income3 months2014-03-30 to 2014-06-28$278.5mus-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
Net income6 months2014-01-01 to 2014-06-28$821.6mus-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
Diluted EPS3 months2014-03-30 to 2014-06-28$0.69us-gaap:EarningsPerShareDiluted
Diluted EPS6 months2014-01-01 to 2014-06-28$2.05us-gaap:EarningsPerShareDiluted
Basic EPS3 months2014-03-30 to 2014-06-28$0.70us-gaap:EarningsPerShareBasic
Basic EPS6 months2014-01-01 to 2014-06-28$2.07us-gaap:EarningsPerShareBasic
Diluted shares (weighted)3 months2014-03-30 to 2014-06-28403,100,000 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Diluted shares (weighted)6 months2014-01-01 to 2014-06-28400,700,000 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Operating cash flow6 months2014-01-01 to 2014-06-28$989.9mus-gaap:NetCashProvidedByUsedInOperatingActivities
Capital expenditure6 months2014-01-01 to 2014-06-28$180.2mus-gaap:PaymentsToAcquirePropertyPlantAndEquipment
Dividends paid6 months2014-01-01 to 2014-06-28$114.7mus-gaap:PaymentsOfDividendsCommonStock
Share repurchases6 months2014-01-01 to 2014-06-28$0us-gaap:PaymentsForRepurchaseOfCommonStock
Cash and equivalentsAt period end2014-06-28$584.9mus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2014-06-28$5.94bnus-gaap:AssetsCurrent
Total assetsAt period end2014-06-28$44.31bnus-gaap:Assets
Current liabilitiesAt period end2014-06-28$6.24bnus-gaap:LiabilitiesCurrent
Current portion of debtAt period end2014-06-28$3.08bnus-gaap:DebtCurrent
Shareholders' equityAt period end2014-06-28$20.66bnus-gaap:StockholdersEquity
Shares outstandingAt period end2014-06-28399,354,992 sharesdei:EntityCommonStockSharesOutstanding

Source: SEC EDGAR, the filing index for accession 0000097745-14-000045. Last ingested by Listed: Nov 14, 2026, 12:05 ET. Listed shows no prices and gives no investment advice.